Skip to content
Medical Health Aged Care

BrainTrack receives international recognition

Dementia Australia 2 mins read

BrainTrack, a free app that helps you privately monitor and understand changes in cognition, received international recognition last week, reaching the finals of the Asia-Pacific Information Communications Technology Alliance (APICTA) Awards in Hong Kong.

BrainTrack, developed by Dementia Australia and Deakin University’s Applied Artificial Intelligence Institute (A²I²) Institute, reached the finals of the Health and Wellbeing category at the awards, which recognise excellence and creativity in the technology sector.

Dementia Australia CEO Maree McCabe AM said it was fantastic to see BrainTrack, which has been downloaded more than 60,000 times since being launched in October 2022, receive international recognition.

“With more than 400,000 Australians living with dementia – which is projected to increase to more than 800,000 by 2058 – improving early diagnosis must be a priority,” Ms McCabe said.

BrainTrack helps individuals explore common cognitive concerns and provides brain health information through fun, travel-themed games that have been adapted from validated cognitive testing. Users can share their results with their GP to support the early identification of cognitive changes over time that may warrant further testing.

“I congratulate the incredible team behind this groundbreaking tool that is increasing the understanding of dementia and raising awareness about the importance of monitoring and talking about brain health,” Ms McCabe said.

“We won our first APICTA in 2014 for our Virtual Dementia Experience. It is so exciting to be recognised once more by these prestigious, international awards.”

BrainTrack was also recently named the Best App for Good for 2023 by Google Play.

BrainTrack is available for download for free through the Apple App Store or Google Play. For more information, please visit www.dementia.org.au/braintrack or call the National Dementia Helpline on 1800 100 500.

Dementia Australia qualified to compete in the international APICTA Awards after winning the Community/Not-for-profit category in the ACT and then the National 2023 Australian Information Industry Association iAwards.

The development of BrainTrack was funded by the Australian Government.

To view all Dementia Australia’s awards and recognition go to https://www.dementia.org.au/about-us/dementia-australia/awards-and-recognition

Dementia Australia is the source of trusted information, education and services for the estimated more than 400,000 Australians living with dementia, and the more than 1.5 million people involved in their care. We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible. No matter how you are impacted by dementia or who you are, we are here for you.


For support, please contact the National Dementia Helpline on 1800 100 500. An interpreter service is available. The National Dementia Helpline is funded by the Australian Government. People looking for information can also visit dementia.org.au

-Ends-

Media contacts: Catherine McCarthy, Media and Communications Advisor, 0466 796 201, Catherine.McCarthy@dementia.org.au

When talking or writing about dementia please refer to Dementia-Friendly Language Guidelines.

Note to Editors:
We request, where possible, details for the National Dementia Helpline 1800 100 500 appear alongside news stories about dementia, as these stories often prompt questions or concerns:

If this story has prompted any questions or concerns, please call the National Dementia Helpline 1800 100 500 (24 hours, 7 days a week) or visit dementia.org.au.

More from this category

  • Medical Health Aged Care, Research Development
  • 06/09/2024
  • 15:19
La Trobe University

Breakthrough in the hunt for broad-spectrum malaria therapy

Scientists at La Trobe University have discovered a new antibody-like molecule which could be used in therapy to prevent infection from multiple malaria parasite species. The research, recently published in Nature Communications, found that when the molecule WD34 binds with a protein produced by malaria parasites, it inhibits their ability to infect cells at different stages of the disease. Led by Professor Michael Foley, Professor Robin Anders and PhD candidate Dimuthu Angage at the La Trobe Institute for Molecular Science (LIMS), the research also showed that WD34 can protect against several different malaria parasite species. Professor Foley said the discovery…

  • Medical Health Aged Care
  • 06/09/2024
  • 10:16
Royal Australian College of GPs

NSW Government’s expanded role for pharmacy is reckless and unsafe for patients: RACGP

The New South Wales Government’s move to expand the scope of pharmacists to treat a range of conditions is politically driven and risks the health of people across the state, says the Royal Australian College of GPs. Health Minister Ryan Park made the announcement at a Pharmacy Guild conference last night that work was underway to expand pharmacists' scope to treat ear infections, wound management, nausea, gastro-oesophageal reflux disease, acne, and muscle and joint pain. RACGP NSW Chair Dr Rebekah Hoffman slammed the move as reckless and putting politics before patient safety. “This is politically driven policy, and it has…

  • CharitiesAidWelfare, Medical Health Aged Care
  • 06/09/2024
  • 05:00
Lloyds Auctioneers and Valuers

Bid for a Cause: Whisky Auction Supports Brain Cancer Fight

After Jack was diagnosed with Glioblastoma Multiforme (GBM), one of the most aggressive and deadly brain cancers, he was given just 12 months to…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.